Highlights
- Developed an oral arsenic preparation to treat leukaemia, a first patented prescription drug developed entirely in Hong Kong
- Identified and characterised cancer stem cells responsible for metastasis in colorectal cancer, and the development of liver cancer
- Discovered a new mechanism causing Lynch Syndrome that has become a diagnostic test adopted worldwide
- Established zebrafish as a model organism for acute myeloid leukaemia (AML) and identified novel therapeutic regimens for specific AML subtypes that improve patient outcomes
- Hepatitis B virus infection and hepatocellular carcinoma: from diagnosis and treatment of chronic carrier status, mechanisms of hepatocellular carcinogenesis, to development of novel treatment modalities including live-donor liver transplantation
- Groundbreaking and comprehensive genomic study of gastric and liver cancers
RGC Theme-based Research / Area of Excellence Scheme
-
Project Coordinator: Professor Stephanie Kwai-yee MA (2025)
-
Project Coordinator: Professor Xin-Yuan GUAN (2024)
-
Project Coordinator: Professor Xin-Yuan GUAN
-
Project Coordinator: Professor Irene Oi-lin NG
-
Project Coordinator: Professor Anskar Yu-hung LEUNG (2020)
-
Project Coordinator: Professor Chung-mau LO (2019)
-
Project Coordinator: Professor Maria Li LUNG (2017)
-
Project Coordinator: Professor Irene Oi-lin NG (2016)
-
Project Coordinator: Professor Suet-Yi LEUNG (2016)
-
Project Coordinator: Professor Maria Li LUNG (2010)
RGC Research Impact Fund
- Project Coordinator: Professor Jack Chun-ming WONG (2026)
- Project Coordinator: Professor Stephanie Kwai-yee MA (2021)
State Key Laboratory
Other Strategic Project
Follow HKUMed